Volume 8, Issue 2 (2023)                   SJMR 2023, 8(2): 119-124 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nateghi M R, Saremi A, Abbasi B, Mokamelsefat L, Karimi-MansourAbad E. Understanding the Link Between Gestational Diabetes and Intrauterine Growth Restriction: A Comprehensive Narrative Review. SJMR 2023; 8 (2) : 6
URL: http://saremjrm.com/article-1-300-en.html
1- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran.
2- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran & Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
3- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran.
Abstract:   (520 Views)
Gestational diabetes is a condition that affects a substantial number of expectant mothers, with profound implications for maternal and fetal health. Among its complications, intrauterine growth restriction (IUGR) has garnered significant scientific attention. IUGR, characterized by impaired fetal growth, presents both immediate and long-term health risks. The relationship between gestational diabetes and IUGR has been a subject of extensive investigation, with studies exploring its nature and strength. IUGR, arising from gestational diabetes, is a matter of growing concern due to its potential impacts on both mothers and infants. This narrative review aims to consolidate existing knowledge on this topic, discerning the connection between gestational diabetes and IUGR.
We provide a detailed comparison of IUGR and macrosomia (excessive fetal growth) in patients with gestational diabetes, highlighting the variations in prevalence, risk factors, management, and maternal and neonatal implications. While IUGR is less common (around 5%-10%), macrosomia occurs more frequently (20%-40% or higher) in gestational diabetes cases. The balance between preventing these conditions is a key challenge, requiring vigilant monitoring of blood glucose levels during pregnancy
Article number: 6
Full-Text [PDF 1379 kb]   (233 Downloads)    
Article Type: Analytical Review | Subject: Pregnancy Care
Received: 2023/07/2 | Accepted: 2023/09/6 | Published: 2024/03/16

1. 1. Davenport MH, Meah VL, Ruchat SM, Davies GA, Skow RJ, Barrowman N, et al. Impact of prenatal exercise on neonatal and childhood outcomes: a systematic review and meta-analysis. Br J Sports Med. A 2018;52(21):1386-96. [DOI:10.1136/bjsports-2018-099836]
2. Mao Y, Zhang C, Wang Y, Meng Y, Chen L, Dennis CL, et al. Association Between Paternal Age and Birth Weight in Preterm and Full-Term Birth: A Retrospective Study. Front Endocrinol (Lausanne). A 2021;12:706369. [DOI:10.3389/fendo.2021.706369]
3. Maulik D. Fetal growth restriction and macrosomia: an apparently intriguing combination. J Matern Fetal Neonatal Med. A 2003;13(3):145-6. [DOI:10.1080/713605826]
4. Monk D, Moore GE. Intrauterine growth restriction--genetic causes and consequences. Semin Fetal Neonatal Med. 2004;9(5):371-8. [DOI:10.1016/j.siny.2004.03.002]
5. Romero R, Kingdom J, Deter R, Lee W, Vintzileos A. Fetal Growth: Evaluation and Management. Am J Obstet Gynecol. A 2018;218(2s):S608. [DOI:10.1016/j.ajog.2018.01.010]
6. Dumolt JH, Powell TL, Jansson T. Placental Function and the Development of Fetal Overgrowth and Fetal Growth Restriction. Obstet Gynecol Clin North Am. A 2021;48(2):247-66. [DOI:10.1016/j.ogc.2021.02.001]
7. Hong M, Liang F, Zheng Z, Chen H, Guo Y, Li K, et al. Weight gain rate in the second and third trimesters and fetal growth in women with gestational diabetes mellitus: a retrospective cohort study. BMC Pregnancy Childbirth. 2022;22(1):424. [DOI:10.1186/s12884-022-04762-4]
8. Kajdy A, Modzelewski J, Herman K, Muzyka-Placzynska K, Rabijewski M. Growth charts and prediction of abnormal growth - what is known, what is not known and what is misunderstood. Ginekol Pol. A 2019;90(12):717-21. [DOI:10.5603/GP.2019.0123]
9. Meek CL, Corcoy R, Asztalos E, Kusinski LC, López E, Feig DS, et al. Which growth standards should be used to identify large- and small-for-gestational age infants of mothers with type 1 diabetes? A pre-specified analysis of the CONCEPTT trial. BMC Pregnancy Childbirth. 2021;21(1):96. [DOI:10.1186/s12884-021-03554-6]
10. Sabri A, Lai D, D'Silva A, Seeho S, Kaur J, Ng C, et al. Differential placental gene expression in term pregnancies affected by fetal growth restriction and macrosomia. Fetal Diagn Ther. 2014;36(2):173-80. [DOI:10.1159/000360535]
11. Sibiak R, Jankowski M, Gutaj P, Mozdziak P, Kempisty B, Wender-Ożegowska E. Placental Lactogen as a Marker of Maternal Obesity, Diabetes, and Fetal Growth Abnormalities: Current Knowledge and Clinical Perspectives. J Clin Med. A 2020;9.(4). [DOI:10.3390/jcm9041142]
12. Lewandowska M. Maternal Obesity and Risk of Low Birth Weight, Fetal Growth Restriction, and Macrosomia: Multiple Analyses. Nutrients. 2021;13.(4). [DOI:10.3390/nu13041213]
13. Obesity in Pregnancy: ACOG Practice Bulletin, Number 230. Obstet Gynecol. A 2021;137(6):e128-e44. [DOI:10.1097/AOG.0000000000004395]
14. Mistry SK, Das Gupta R, Alam S, Kaur K, Shamim AA, Puthussery S. Gestational diabetes mellitus (GDM) and adverse pregnancy outcome in South Asia: A systematic review. Endocrinol Diabetes Metab. 2021;4(4):e00285. [DOI:10.1002/edm2.285]
15. Venkatesh KK, Lynch CD, Powe CE, Costantine MM, Thung SF, Gabbe SG, et al. Risk of Adverse Pregnancy Outcomes Among Pregnant Individuals With Gestational Diabetes by Race and Ethnicity in the United States, 2014-2020. Jama. A 2022;327(14):1356-67. [DOI:10.1001/jama.2022.3189]
16. Thekkedathu VC. Maternal and Placental Risk Factors Associated With Intrauterine Growth Restriction and the Perinatal Outcomes. Journal of South Asian Federation of Obstetrics and Gynaecology. 2015. [DOI:10.5005/jp-journals-10006-1351]
17. Nisar S. Doppler evaluation of IUGR babies at a tertiary hospital. Hypertension.5:5. [DOI:10.33545/gynae.2021.v5.i1g.851]
18. Gao X, Lin S, Jiang P-Y, Ye MY, Chen W, Hu CX, et al. Gestational Cholestasis Induced Intrauterine Growth Restriction Through Triggering IRE1α‐mediated Apoptosis of Placental Trophoblast Cells. The Faseb Journal. 2022. [DOI:10.1096/fj.202101844RR]
19. Novitskaya T, Baserga M, Caestecker MPd. Organ-Specific Defects in Insulin-Like Growth Factor and Insulin Receptor Signaling in Late Gestational Asymmetric Intrauterine Growth Restriction in Cited1 Mutant Mice. Endocrinology. 2011. [DOI:10.1210/en.2010-1385]
20. Bedell S, Hutson J, de Vrijer B, Eastabrook G. Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions. Curr Vasc Pharmacol. 2021;19(2):176-92. [DOI:10.2174/18756212MTA3qNDApy]
21. Brown HL, Smith GN. Pregnancy Complications, Cardiovascular Risk Factors, and Future Heart Disease. Obstet Gynecol Clin North Am. 2020;47(3):487-95. [DOI:10.1016/j.ogc.2020.04.009]
22. Damhuis SE, Ganzevoort W, Gordijn SJ. Abnormal Fetal Growth: Small for Gestational Age, Fetal Growth Restriction, Large for Gestational Age: Definitions and Epidemiology. Obstet Gynecol Clin North Am. 2021;48(2):267-79. [DOI:10.1016/j.ogc.2021.02.002]
23. Fasoulakis Z, Koutras A, Antsaklis P, Theodora M, Valsamaki A, Daskalakis G, et al. Intrauterine Growth Restriction Due to Gestational Diabetes: From Pathophysiology to Diagnosis and Management. Medicina (Kaunas). 2023;59.(6). [DOI:10.3390/medicina59061139]
24. Gantenbein KV, Kanaka-Gantenbein C. Highlighting the trajectory from intrauterine growth restriction to future obesity. Front Endocrinol (Lausanne). 2022;13:1041718. [DOI:10.3389/fendo.2022.1041718]
25. Joo EH, Kim YR, Kim N, Jung JE, Han SH, Cho HY. Effect of Endogenic and Exogenic Oxidative Stress Triggers on Adverse Pregnancy Outcomes: Preeclampsia, Fetal Growth Restriction, Gestational Diabetes Mellitus and Preterm Birth. Int J Mol Sci. A2021;22.(18). [DOI:10.3390/ijms221810122]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | {Sarem Journal of Medical Research}

Designed & Developed by : Yektaweb